New hope for leukemia patients: trial tests Next-Generation pill
Disease control
Recruiting now
This study is testing a new daily pill called TERN-701 for adults with chronic myeloid leukemia (CML) who have already tried other treatments. The main goals are to find a safe dose and see if the drug can effectively control the leukemia. The trial will enroll about 180 particip…
Phase: PHASE1, PHASE2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC